For immediate release |
11 December 2018 |
|
|
Gooch & Housego PLC
("G&H" or the "Company")
Gooch & Housego PLC, the specialist manufacturer of optical components and systems, announces that further to the announcement of 11 July 2016 regarding the acquisition of Kent Periscopes, the Company has applied for the admission to trading on AIM of 32,755 new G&H ordinary shares of 20p each, which is expected to commence on 13 December 2018. The shares will be issued pursuant to the deferred contingent consideration based upon the performance of Kent Periscopes since its acquisition.
For further information please contact:
Gooch & Housego PLC
Mark Webster/ Andy Boteler Tel 01460 256440
Buchanan
Mark Court/Sophie Cowles Tel 0207 466 5000
Investec Bank plc, (NOMAD and Broker)
Patrick Robb / David Anderson Tel 0207 597 5970
Notes to editors
1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.
2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.